Why Oncology Billing Is Complex
Oncology practices face some of the most complex billing challenges in healthcare, requiring specialized expertise across chemotherapy, radiation, infusion, and drug management.
Chemotherapy Administration Coding
Chemotherapy administration codes (96400-96549) require precise distinction between IV push, infusion, intra-arterial, and intracavitary routes. Each method has specific time documentation requirements, and the addition of antiemetics or supportive care agents during the same session adds significant coding complexity.
Drug & Biologic J-Code Management
Oncology drugs and biologics billed through HCPCS J-codes (J9000-J9999) present constant challenges with payer-specific coverage policies, off-label use documentation requirements, and average sales price (ASP) reimbursement methodology. Biosimilar coding, wastage documentation, and prior authorization add further complexity.
Radiation Oncology Coding
Radiation oncology codes (77261-77799) span treatment planning, physics/dosimetry, treatment delivery, and management. Proper coding requires understanding of IMRT, SBRT, SRS, brachytherapy, proton beam therapy, and image-guided radiation therapy (IGRT) — each with distinct coding rules and documentation requirements.
Immunotherapy & Clinical Trial Billing
Immunotherapy agents including CAR-T cell therapy, checkpoint inhibitors (PD-1/PD-L1), and bispecific T-cell engagers require specialized coding and prior authorization. Clinical trial billing adds another layer of complexity with coordination between research sponsors, Medicare coverage analysis, and proper qualifying trial determination.